PREMIER VETERINARY GROUP PLC

("PVG" or "the Company")

APPOINTMENT OF CHIEF FINANCIAL OFFICER

London, UK, 20 July 2016 - Premier Veterinary Group plc (LSE: PVG) is pleased to announce that Will Evans has been appointed as Chief Financial Officer and Executive Director of the Company with effect from 19 September 2016.  As announced on 26 April 2016, the Company's current Chief Financial Officer, Daniel Smith, will be leaving but will continue working within the business for a period of time to provide a smooth handover of responsibilities to Will. 

Will Evans joins PVG having previously held a number of senior management and finance positions in other UK listed companies.  From 2009 to 2015, he was at Tribal Group plc where he held roles as Group Financial Controller, Divisional Finance Director for Tribal's Services Division and, most recently, as Corporate Development Director.   Prior to joining Tribal Group plc, he was Group Financial Controller at Synergy Health plc.  Will qualified as a chartered accountant with Arthur Andersen.

There are no disclosures required to be made under LR 9.6.13.

Dominic Tonner, Chief Executive Officer commented:

"I am delighted to have Will join the PVG team.  He will further strengthen the depth of our executive resource as we continue with our global expansion plans.  His skill set will undoubtedly be of enormous help in delivering value to the Company and its shareholders."

For further information, please contact:

Premier Veterinary Group plc                                                  Tel: +44 (0)117 970 4130

Juliet Thompson, Non-Executive Chairman

Dominic Tonner, Chief Executive Officer                                         

Daniel Smith, Chief Financial Officer

Zeus Capital Limited                                                                 Tel: +44 (0)203 829 5000

Giles Balleny, Director, Corporate Finance

Hugh Kingsmill Moore, Director, Sales                                 

Square1 Consulting                                                                  Tel: +44 (0)207 929 5599

David Bick

Brian Alexander

Note to Editors:

PVG's services to third party veterinary practices, through its wholly-owned subsidiary Premier Vet Alliance Limited ("PVA"), include the administration and support of a preventative healthcare program for pets branded "Premier Pet Care Plan" ("PPCP"); and the operation of a buying group (the "PVA Buying Group") which offers enhanced discounts to member practices on pharmaceutical and consumable spending.  In the US, Premier Pet Care Plan is marketed through the Company's wholly-owned subsidiary, Premier Vet Alliance (US) Limited.

PPCP is a structured, preventative healthcare program for cats, dogs and rabbits and is available only through veterinary practices. The program is seen as a way of providing gold standard care for pets at an affordable price for the client, by way of fixed monthly payments.

PPCP uses a clinical approach to prevention, as this is the most effective method of ensuring illnesses are diagnosed more quickly and not given a chance to advance. What truly sets PPCP apart is its unique approach of offering an end-to-end solution and support to the practice, which has been proven to work extremely well. PVA works alongside practices to create a tailor-made, cost-effective service for clients, one that delivers excellent care to their patients and significantly improves practice performance.

The PVA Buying Group, is now the UK's largest veterinary buying group without group interests in veterinary practices or veterinary wholesalers offering its members the best discounts across the industry on pharmaceutical and consumable spend.

For further details: http://www.premiervetalliance.co.uk/

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company's control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.